Progenity Provides Corporate Update and Reports Fourth Quarter and Full Year 2021 Financial Results

Provided By Globe Newswire

Last update: Mar 28, 2022

Accelerated Company Transformation Toward Oral Delivery of Biotherapeutics and Targeted Therapeutics Programs

Progressed Company’s Targeted Therapeutics Clinical Programs with Initiation of Clinical Device Performance Study in Patients with Ulcerative Colitis